12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Thursday's intraday session, several healthcare stocks experienced significant movements. Rallybio, Eliem Therapeutics, and Candel Therapeutics were among the top gainers, with shares increasing by 70.5%, 57.3%, and 40.58% respectively. Conversely, Aptevo Therapeutics, AVITA Medical, and BioSig Technologies were the leading losers, with their shares falling by 57.9%, 30.61%, and 25.35% respectively. These movements reflect notable volatility within the healthcare sector.
April 11, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aptevo Therapeutics shares plummeted by 57.9% to $1.01, indicating a sharp decline.
The dramatic decrease in Aptevo Therapeutics' stock price could reflect negative clinical trial results, financial distress, or other adverse news, likely leading to a bearish short-term outlook.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
BioSig Technologies stock fell 25.35% to $1.5, indicating a considerable loss in value.
The decline in BioSig Technologies' share price could be attributed to disappointing company news or market reactions, suggesting a negative short-term outlook for the stock.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
AVITA Medical shares declined by 30.61% to $10.02, showing a significant downturn.
The substantial drop in AVITA Medical's stock price suggests negative developments or investor dissatisfaction, which could continue to impact the stock negatively in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Candel Therapeutics shares increased by 40.58% to $7.17, marking a notable gain.
The significant rise in Candel Therapeutics' shares could be driven by positive clinical trial results or other favorable company news, suggesting a bullish outlook in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Eliem Therapeutics shares rose 57.3% to $4.2, showcasing a strong upward trend.
Eliem Therapeutics' significant price increase suggests positive developments or investor optimism, which could maintain upward pressure on the stock in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Rallybio shares surged 70.5% to $2.78, reflecting a significant positive movement.
The substantial increase in Rallybio's stock price indicates strong investor confidence or positive news related to the company, likely leading to continued short-term bullish sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90